Patents by Inventor Adrian N. Hobden

Adrian N. Hobden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Variants of antithrombin III
    Patent number: 7482139
    Abstract: Disclosed are compositions and methods related to variant antithrombin III molecules.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: January 27, 2009
    Assignee: University of Utah Research Foundation
    Inventors: Susan C. Bock, Adrian N. Hobden
  • Gene expression in yeast cells
    Patent number: 5238822
    Abstract: A transformed yeast cell containing the following DNA sequences,an HIV tat gene coding for a TAT protein,a first promoter exercising transcriptional control over the tat gene,an HIV regulatory control sequence which is responsive to the TAT protein,a pre-selected gene coding for a desired polypeptide or protein, the pre-selected gene being under the control of the HIV regulatory control sequence, anda second promoter exercising transcriptional control over the HIV regulatory control sequence and the pre-selected gene.Preferably the first and second promoters are yeast promoters, the transformed yeast cell is a S.cerevisiae cell and the HIV regulatory control sequence is a TAT responsive TAR sequence.The transformed yeast cells may be used to screen for agents that inhibit the function of TAT protein.
    Type: Grant
    Filed: February 5, 1991
    Date of Patent: August 24, 1993
    Assignee: Glaxo Group Limited
    Inventors: Colin W. Dykes, Joachim F. Ernst, Adrian N. Hobden